Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy

Benedikt Fritzsching; Marco Contoli; Celeste Porsbjerg; Sarah Buchs; Julie Rask Larsen; Nick Freemantle

doi:10.1016/j.jaci.2021.12.781

Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy

J Allergy Clin Immunol. 2022 Mar;149(3):881-883. doi: 10.1016/j.jaci.2021.12.781. Epub 2021 Dec 30.

Authors

Benedikt Fritzsching¹, Marco Contoli², Celeste Porsbjerg³, Sarah Buchs⁴, Julie Rask Larsen⁴, Nick Freemantle⁵

Affiliations

¹ Paediatric Pulmonology and Allergy, Children's Doctor Service, University of Heidelberg, Heidelberg, Germany. Electronic address: Prof.Fritzsching@kinderarzt-hd.de.
² Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
³ Department of Respiratory Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
⁴ ALK-Abelló, Hørsholm, Denmark.
⁵ Institute of Clinical Trials and Methodology UCL, London, United Kingdom.

PMID: 34973297
DOI: 10.1016/j.jaci.2021.12.781

No abstract available

Keywords: Allergic rhinitis; RCT; allergy; allergy immunotherapy; asthma; effectiveness; long-term follow-up; methodology; real-world evidence; retrospective cohort study; study design.

Publication types

Editorial

MeSH terms

Desensitization, Immunologic
Humans
Immunotherapy
Rhinitis, Allergic*